{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:00:06Z","timestamp":1791032406474,"version":"4.1.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2009,12,31]],"date-time":"2009-12-31T00:00:00Z","timestamp":1262217600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0008490","type":"journal-article","created":{"date-parts":[[2009,12,30]],"date-time":"2009-12-30T21:19:49Z","timestamp":1262207989000},"page":"e8490","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":104,"title":["Cellular Levels of HIV Unspliced RNA from Patients on Combination Antiretroviral Therapy with Undetectable Plasma Viremia Predict the Therapy Outcome"],"prefix":"10.1371","volume":"4","author":[{"given":"Alexander O.","family":"Pasternak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Jurriaans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Berkhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir V.","family":"Lukashov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,12,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.","volume":"337","author":"SM Hammer","year":"1997","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM199709113371102","article-title":"Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.","volume":"337","author":"RM Gulick","year":"1997","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"F117","DOI":"10.1097\/00002030-199811000-00003","article-title":"Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy.","volume":"12","author":"GJ Weverling","year":"1998","journal-title":"AIDS"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.","volume":"338","author":"FJ Palella Jr","year":"1998","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/505147","article-title":"The survival benefits of AIDS treatment in the United States.","volume":"194","author":"RP Walensky","year":"2006","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00002030-200201040-00004","article-title":"Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen.","volume":"16","author":"V Le Moing","year":"2002","journal-title":"AIDS"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1086\/343801","article-title":"Human immunodeficiency virus rebound after suppression to &lt;400 copies\/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression.","volume":"186","author":"AN Phillips","year":"2002","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-1293.2008.00650.x","article-title":"Factors associated with viral rebound among highly treatment-experienced HIV-positive patients who have achieved viral suppression.","volume":"10","author":"CJ Smith","year":"2009","journal-title":"HIV Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/466534","article-title":"The rate of viral rebound after attainment of an HIV load &lt;50 copies\/mL according to specific antiretroviral drugs in use: results from a multicenter cohort study.","volume":"192","author":"CJ Smith","year":"2005","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1097\/00002030-200308150-00003","article-title":"Virological rebound after suppression on highly active antiretroviral therapy.","volume":"17","author":"A Mocroft","year":"2003","journal-title":"AIDS"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/00002030-200409030-00008","article-title":"Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppression.","volume":"18","author":"AN Phillips","year":"2004","journal-title":"AIDS"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1086\/314890","article-title":"CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus load.","volume":"180","author":"V Miller","year":"1999","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1097\/00002030-200411190-00006","article-title":"Cellular HIV-1 DNA load predicts HIV-RNA rebound and the outcome of highly active antiretroviral therapy.","volume":"18","author":"AE Hatzakis","year":"2004","journal-title":"AIDS"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/jama.286.2.196","article-title":"HIV-1 drug resistance profiles in children and adults with viral load of &lt;50 copies\/ml receiving combination therapy.","volume":"286","author":"M Hermankova","year":"2001","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1128\/JVI.00591-06","article-title":"Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells.","volume":"80","author":"JR Bailey","year":"2006","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1172\/JCI9006","article-title":"A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.","volume":"105","author":"D Persaud","year":"2000","journal-title":"J Clin Invest"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1128\/JVI.77.10.5721-5730.2003","article-title":"Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy.","volume":"77","author":"LM Frenkel","year":"2003","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1128\/JVI.79.15.9625-9634.2005","article-title":"Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.","volume":"79","author":"NH Tobin","year":"2005","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/71577","article-title":"The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.","volume":"6","author":"B Ramratnam","year":"2000","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJM199905273402101","article-title":"Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.","volume":"340","author":"L Zhang","year":"1999","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1172\/JCI26197","article-title":"HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.","volume":"115","author":"TW Chun","year":"2005","journal-title":"J Clin Invest"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"16725","DOI":"10.1073\/pnas.0804192105","article-title":"HIV rebounds from latently infected cells, rather than from continuing low-level replication.","volume":"105","author":"B Joos","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"11212","DOI":"10.1128\/JVI.77.20.11212-11219.2003","article-title":"Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years.","volume":"77","author":"DV Havlir","year":"2003","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1371\/journal.ppat.0030046","article-title":"ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia.","volume":"3","author":"F Maldarelli","year":"2007","journal-title":"PLoS Pathog"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.0800050105","article-title":"Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy.","volume":"105","author":"S Palmer","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1073\/pnas.0903107106","article-title":"Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.","volume":"106","author":"JB Dinoso","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/JCM.00055-08","article-title":"Highly sensitive methods based on seminested real-time reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 unspliced and multiply spliced RNA and proviral DNA.","volume":"46","author":"AO Pasternak","year":"2008","journal-title":"J Clin Microbiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/135965350200700203","article-title":"Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts.","volume":"7","author":"M Fischer","year":"2002","journal-title":"Antivir Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1742-4690-5-107","article-title":"Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy.","volume":"5","author":"M Fischer","year":"2008","journal-title":"Retrovirology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1056\/NEJM199905273402102","article-title":"Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.","volume":"340","author":"MR Furtado","year":"1999","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.1128\/JVI.77.13.7383-7392.2003","article-title":"Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.","volume":"77","author":"M Hermankova","year":"2003","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1086\/504264","article-title":"Long-term decay of the HIV-1 reservoir in HIV-1-infected children treated with highly active antiretroviral therapy.","volume":"193","author":"M Zanchetta","year":"2006","journal-title":"J Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1128\/JVI.73.7.6099-6103.1999","article-title":"Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy.","volume":"73","author":"SR Lewin","year":"1999","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/jmv.20993","article-title":"Frequent detection of cell-associated HIV-1 RNA in patients with plasma viral load &lt;50 copies\/ml.","volume":"79","author":"B Kupfer","year":"2007","journal-title":"J Med Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1128\/JVI.00570-09","article-title":"Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapy.","volume":"83","author":"C Shiu","year":"2009","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaci.2008.05.033","article-title":"Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection.","volume":"122","author":"L Shen","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/387183a0","article-title":"Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.","volume":"387","author":"TW Chun","year":"1997","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.","volume":"278","author":"D Finzi","year":"1997","journal-title":"Science"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.","volume":"9","author":"JD Siliciano","year":"2003","journal-title":"Nat Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1128\/JVI.70.11.7603-7613.1996","article-title":"Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo.","volume":"70","author":"P Bagnarelli","year":"1996","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1097\/00002030-200012220-00001","article-title":"Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection.","volume":"14","author":"S Yerly","year":"2000","journal-title":"AIDS"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/387188a0","article-title":"Decay characteristics of HIV-1-infected compartments during combination therapy.","volume":"387","author":"AS Perelson","year":"1997","journal-title":"Nature"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.189.10.1545","article-title":"Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.","volume":"189","author":"RD Hockett","year":"1999","journal-title":"J Exp Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/510752","article-title":"Drug resistance after failure of initial antiretroviral therapy in resource-limited countries.","volume":"44","author":"JE Gallant","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref45","article-title":"Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a Public Health approach. 2006 revision.","author":"C Gilks","year":"2006"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/JCM.28.3.495-503.1990","article-title":"Rapid and simple method for purification of nucleic acids.","volume":"28","author":"R Boom","year":"1990","journal-title":"J Clin Microbiol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0008490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T09:47:36Z","timestamp":1685353656000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0008490"}},"subtitle":[],"editor":[{"given":"Fatah","family":"Kashanchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,12,31]]},"references-count":46,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2009,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0008490","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,31]]}}}